Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
The SAR development of substituted purine derivatives as selective CB2 agonists for the treatment of chronic pain.
Journal: Bioorganic & medicinal chemistry letters
Published: August 27, 2014
Selective cannabinoid receptor type 2 (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic pain.
Journal: Journal of medicinal chemistry
Published: June 26, 2013
Showing 1-2 of 2
Last Updated: 09/26/2026